Assignee
GC CELL CORP
KR8 patents
Top patents by PatentIndex Score
US12116417B2Oct 15, 2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
GC CELL CORP2 citations71
US11970547B2Apr 30, 2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
GC CELL CORP2 citations69
US11649294B2May 16, 2023
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
GC CELL CORP3 citations69
US11766456B2Sep 26, 2023
Method for culturing natural killer cells using T cells
GC CELL CORP2 citations65
US12410261B2Sep 9, 2025
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
GC CELL CORP0 citations59
US12203065B2Jan 21, 2025
Method for culturing natural killer cell, using transformed T cell
GC CELL CORP0 citations56
US12491244B2Dec 9, 2025
Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and natural killer cell
GC CELL CORP0 citations54
US12435118B2Oct 7, 2025
Chimeric antigen receptor and natural killer cells expressing same
GC CELL CORP0 citations54